BCRP (ABCG2)

➦ The ATP-dependent efflux transporter BCRP (Breast Cancer Resistance Protein) functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Recently it has been shown to transport organic anions but also steroids like cholesterol, estradiol, progesterone, and testosterone.

Main localization:Liver, kidney, placenta (apical membranes)
Transporter assay:Vesicle-based transporter assay (potential inhibitors or substrates)
Probe substrates:Estrone-3-sulfate
Probe inhibitors:Ko143, Elacridar, Sulfasalazine
Regulatory relevance:FDA and EMA guidance
Important interacting drugs:Elacridar (GF120918), Statins, Ritonavir, Cyclosporine
From other species:mBcrp

➦ Concentration dependent inhibition of hBCRP-mediated ES uptake by the probe inhibitor Elacridar (GF120918)

hBCRP (ABCG2)
PortaCellTec Biosciences GmbH • Organic anion transporter, Organic cation transporter, Drug transporter, Transporter assays, Transport proteins, Hepatic uptake transporter, Renal uptake transporter, Drug interaction, Inhibition, IC50, In vitro study, Carrier protein, OAT1, OAT3, OCT1, OCT2, OATP1B1, OATP1B3, SLC22A, SLCO1B1, SLCO1B3, FDA recommended, EMA recommended, MDR1, BCRP, BSEP, MATE1, MATE2K, OATP2A1, OATP1A2, PEPT, OCTN, MRP, OATPs, OCTs, OATs, MATEs, ABC family transporter, SLC family transporter